Copyright
©The Author(s) 2020.
World J Hepatol. Jul 27, 2020; 12(7): 350-362
Published online Jul 27, 2020. doi: 10.4254/wjh.v12.i7.350
Published online Jul 27, 2020. doi: 10.4254/wjh.v12.i7.350
Figure 3 Hepatic sirtuin 1 protein expression in obese mice treated with or without ipragliflozin and their lean littermates.
A: Representative western blot showing the expression of hepatic sirtuin 1 (SIRT1) protein at the end of the treatment period; B: The bar graph below shows the expression of SIRT1 normalized to α-tubulin. bP < 0.01 vs the ob/ob group. Ipra: Ipragliflozin; ob/ob: Obese; SIRT1: Sirtuin 1; α-TUB: α-tubulin. n = 8.
- Citation: Suga T, Sato K, Ohyama T, Matsui S, Kobayashi T, Tojima H, Horiguchi N, Yamazaki Y, Kakizaki S, Nishikido A, Okamura T, Yamada M, Kitamura T, Uraoka T. Ipragliflozin-induced improvement of liver steatosis in obese mice may involve sirtuin signaling. World J Hepatol 2020; 12(7): 350-362
- URL: https://www.wjgnet.com/1948-5182/full/v12/i7/350.htm
- DOI: https://dx.doi.org/10.4254/wjh.v12.i7.350